Hints and tips:
...Charles River Laboratories, the US drug research company, has called off a $1.6bn (€1.23bn, £1.02bn) deal to buy China’s WuXi PharmaTech after its largest shareholders voiced strong opposition and influential...
...If Charles River Laboratories had gone ahead with next week’s shareholder vote on its proposed acquisition of Wuxi PharmaTech – which could have been China’s biggest inbound takeover yet – it would have...
International Edition